Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NTHI | Common Stock | Other | $0 | -4.08K | -1.81% | $0.00 | 221K | Mar 26, 2025 | By HCWG LLC. | F1, F2, F3 |
transaction | NTHI | Common Stock | Exercise of in-the-money or at-the-money derivative security | $956K | +79.7K | +36.09% | $12.00 | 300K | Mar 26, 2025 | By HCWG LLC | F4 |
transaction | NTHI | Common Stock | Sale | -$956K | -38.3K | -12.73% | $25.00 | 262K | Mar 26, 2025 | By HCWG LLC | |
transaction | NTHI | Common Stock | Sale | -$18.8K | -983 | -0.37% | $19.13 | 261K | Mar 26, 2025 | By HCWG LLC | |
holding | NTHI | Common Stock | 546K | Mar 26, 2025 | See footnote 4. | F5 | |||||
holding | NTHI | Common Stock | 888K | Mar 26, 2025 | By NeuCen Biomedical Co. Ltd. | F6 | |||||
holding | NTHI | Common Stock | 2.83M | Mar 26, 2025 | By TR Chen Third Family Limited Partnership. | F7 | |||||
holding | NTHI | Common Stock | 93.3K | Mar 26, 2025 | By Tien Duan Chen Trust. | F7 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NTHI | Warrant (right to buy) | Exercise of in-the-money or at-the-money derivative security | $0 | -79.7K | -100% | $0.00 | 0 | Mar 26, 2025 | Common Stock | 79.7K | $12.00 | By HCWG | F8 |
Id | Content |
---|---|
F1 | Transfer of shares of common stock held by HCWG LLC pursuant to agreement. |
F2 | Not applicable. Number of shares transferred was based on a per share value of $18. |
F3 | The shares reported herein represent only Reporting Person's percentage interest in HCWG LLC. |
F4 | On 3/26/2025, in conjunction with Issuer's initial listing on Nasdaq, HCWG exercised a warrant to purchase 312,500 shares of Issuer's common stock at $12 per share. HCWG paid the exercise price on a cashless basis, resulting in Issuer's withholding 150,000 of the warrant shares to pay the exercise price and issuing to HCWG the remaining 162,500 shares of common stock. Number of shares reported herein as acquired and disposed of by the Reporting Person represents Reporting Person's indirect interest in HCWG. |
F5 | Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein. |
F6 | Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein. |
F7 | Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein. |
F8 | Not applicable. |